Entasis Therapeutics is a startup based in the United States.
Entasis Therapeutics is a startup based in the United States.
Entasis Therapeutics is a biopharmaceutical company developing antibiotics and adjunctive therapies to treat serious Gram-negative bacterial infections. The company focuses on small-molecule antibacterial agents, including inhibitors aimed at overcoming beta-lactamase–mediated resistance.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.